References
- Esposito S, Noviello S, Pagliano P. Update on treatment of COVID-19: ongoing studies between promising and disappointing results. Infez Med. 2020;28(2):198–211.
- Colson P, Rolain JM, Lagier JC, et al. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents. 2020;55(4):105932.
- Molina JM1, Delaugerre C, Le Goff J, et al. N3. No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection. Med Mal Infect. 2020;50(4):384.
- Alexander PE, Debono VB, Mammen MJ, et al. COVID-19 research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine. J Clin Epidemiol. 2020.
- Interim clinical guidance for adults with suspected or confirmed COVID-19 in Belgium. 07 April 2020. Version 7. Available from: https://covid-19.sciensano.be/sites/default/files/Covid19/COVID-19_InterimGuidelines_Treatment_ENG.pdf.
- FDA-Approved Drugs. Approval date(s) and history, letters, labels, reviews for NDA 009768. PLAQUENIL. Labeling-Package Insert. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/009768s037s045s047lbl.pdf.
- Richardson SR, O’Malley GF. Glucose 6 phosphate dehydrogenase (G6PD) deficiency. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020–2019.
- Chew CY, Mar A, Nikpour M, et al. Hydroxychloroquine in dermatology: new perspectives on an old drug. Australas J Dermatol. 2020;61(2):e150–e157.
- Mohammad S, Clowse MEB, Eudy AM, et al. Examination of hydroxychloroquine use and hemolytic anemia in G6PDH-deficient patients. Arthritis Care Res (Hoboken). 2018;70(3):481–485.
- Beauverd Y, Adam Y, Assouline B, et al. COVID-19 infection and treatment with hydroxychloroquine cause severe haemolysis crisis in a patient with glucose-6-phosphate dehydrogenase deficiency. Eur J Haematol. 2020. DOI:10.1111/ejh.13432
- Lee J, Poitras BT. Prevalence of glucose-6-phosphate dehydrogenase deficiency, U.S. Armed Forces, May 2004-September 2018. MSMR. 2019;26(12):14–17.
- Caplan AL1, Upshur R. Panic prescribing has become omnipresent during the COVID-19 pandemic. J Clin Invest. 2020;139562. DOI:10.1172/JCI139562